Trials - Repurposed drugs

Our Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop, or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.Read more

Trials pending

Our Linked Clinical Trials committee annually assesses favourable drugs which, in studies, have demonstrated putative disease-modifying action in Parkinson's - we are actively committed to bringing these to trial.Read more

Regenerative trials - GDNF

Regenerative medicine offers hope for a fundamental cure and continues to make substantial progress in Parkinson's.Read more

Trial selection process

By streamlining our trials we provide a foundation to make accurate comparisons between trials to then determine the greatest effect for progression into the clinic.Read more

Linked Clinical Trial partnership

We have partnered with the Van Andel Research Institute (VARI) - an independent nonprofit biomedical research and science education organisation - for our Linked Clinical Trials programme.Read more

Regenerative medicine - TRANSEURO

We are supporting large surgical trials of transplantation of neural tissue.Read more